Literature DB >> 19421225

Urinary albumin excretion is associated with true resistant hypertension.

A Oliveras1, P Armario, R Hernández-Del Rey, J A Arroyo, E Poch, M Larrousse, A Roca-Cusachs, A de la Sierra.   

Abstract

Resistant (or refractory) hypertension (RH) is a clinical diagnosis based on blood pressure (BP) office measurements. About one third of subjects with suspected RH have indeed pseudo-resistant hypertension and 24-h ambulatory-blood pressure-monitoring aids to precisely identify them. Our aim was to determine those clinical, laboratory or echocardiographic variables that may be associated with subjects with sustained hypertension (namely true RH). We carried out a cross-sectional analysis of 143 patients consecutively enrolled with the clinical diagnosis of RH. All patients underwent clinical-demographic, laboratory evaluation, 2D-echocardiography and 24-h ambulatory-blood pressure-monitoring. Pseudo-resistant hypertension or white-coat RH was defined if office BP was > or =140 and/or 90 mm Hg and 24-h BP <130/80 mm Hg. One-hundred and three (72%) patients had true RH and 40 (28%) patients had white-coat RH. True RH patients had significantly higher diabetes prevalence and higher office-systolic blood pressure (SBP) levels. Regarding target organ damage, left ventricular mass index (LVMI) and 24-h urinary albumin excretion (UAE) were also higher in true RH after adjustment for possible confounders (P=0.031 and P=0.012, respectively). In a logistic regression analysis, only office-SBP (multivariate OR (95%CI): 1.030 (1.003-1.057), P=0.030) and UAE (multivariate OR (95% CI): 2.376 (1.225-4.608), P=0.010) were independently associated with true RH. We conclude that true resistant hypertension is associated with silent target organ damage, especially UAE. In patients with suspected RH, assessment of 24 h ambulatory BP is the most accurate way to detect a population with high risk for target-organ damage.

Entities:  

Mesh:

Year:  2010        PMID: 19421225     DOI: 10.1038/jhh.2009.35

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  12 in total

Review 1.  Detection and treatment of resistant hypertension.

Authors:  Julian Segura; Alejandro de la Sierra; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2010-10       Impact factor: 5.369

Review 2.  Ambulatory Blood Pressure Monitoring in the Diagnosis, Prognosis, and Management of Resistant Hypertension: Still a Matter of our Resistance?

Authors:  Antonios A Lazaridis; Pantelis A Sarafidis; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2015-10       Impact factor: 5.369

Review 3.  Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.

Authors:  Rikki M Tanner; David A Calhoun; Emmy K Bell; C Barrett Bowling; Orlando M Gutiérrez; Marguerite R Irvin; Daniel T Lackland; Suzanne Oparil; William McClellan; David G Warnock; Paul Muntner
Journal:  Am J Kidney Dis       Date:  2014-01-01       Impact factor: 8.860

4.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 5.  Resistant hypertension: patient characteristics, risk factors, co-morbidities and outcomes.

Authors:  A Oliveras; A de la Sierra
Journal:  J Hum Hypertens       Date:  2013-08-29       Impact factor: 3.012

Review 6.  Renal denervation--implications for chronic kidney disease.

Authors:  Roland Veelken; Roland E Schmieder
Journal:  Nat Rev Nephrol       Date:  2014-04-15       Impact factor: 28.314

7.  Resistant hypertension: a therapeutic challenge.

Authors:  Laura Brandani
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-05       Impact factor: 3.738

8.  Clinical characteristics, target organ damage and associate risk factors of resistant hypertension determined by ambulatory blood pressure monitoring in patients aged ≥ 80 years.

Authors:  Zhi-Ru Liang; Ling-Gen Gao; Jian Cao; Hua Cui; Li Fan; De-Wei Gao
Journal:  J Geriatr Cardiol       Date:  2017-05       Impact factor: 3.327

9.  Modulatory effects of hydrochlorothiazide and triamterene on resistant hypertension patients.

Authors:  Haibin Gong; Yun Li; Cheng Zheng; Tian-Tian Du; Bing-Quan Luo; Min Pang
Journal:  Exp Ther Med       Date:  2017-04-28       Impact factor: 2.447

Review 10.  Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!

Authors:  Giuseppe Maiolino; Matteo Azzolini; Gian Paolo Rossi
Journal:  Front Cardiovasc Med       Date:  2015-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.